Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma

Oncology

Volumn 60, Issue 2, 2001, Pages 162-169

  Furudoi, Akira ^a   Tanaka, Shinji ^a   Haruma, Ken ^a   Yoshihara, Masaharu ^a   Sumii, Koji ^a   Kajiyama, Goro ^a   Shimamoto, Fumio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal carcinoma; Glut1; Ki 67; Prognosis

Indexed keywords

CARRIER PROTEIN; GLUCOSE TRANSPORTER; KI 67 ANTIGEN; POLYCLONAL ANTIBODY; STREPTAVIDIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL PROLIFERATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; GLUCOSE TRANSPORT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MONOSACCHARIDE TRANSPORT PROTEINS; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035085695     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055314     Document Type: Article

References (44)

1. Sugar and amino acid transport by cells in culture - Differences between normal and malignant cells
2. 18F] fluroro-D-glucose in liver metastasis from colon carcinoma
3. Substrate balances across colonic carcinoma in humans
4. Nutritional and physiological consequences of tumour glycolysis
5. On the origin of cancer cells
6. Mammalian facilitative glucose transporter family: Structure and molecular regulation
7. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes
8. Platelet-derived growth factor regulates glucose transporter expression
9. Growth factors rapidly induce expression of the glucose transporter gene
10. Differential regulation of glucose transporter 1 and 2 mRNA expression by epidermal growth factor and transforming growth factor-beta in rat hepatocytes
11. Growth factors, mitogens, oncogenes and the regulation of glucose transport
12. Facilitative glucose transporters
13. Brain-type glucose transporter (GLUT1) is selectively localized to the blood-brain barrier
14. The blood-nerve barrier is rich in glucose transporter
15. Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human placental villi
16. Wide expression of the human erythrocyte glucose transporter Glut1 in human cancers
17. Over-expression of facilitative glucose transporter genes in human cancer
18. Overexpression of Glut-1 glucose transporter in human breast cancer
19. Expression of glucose transportes in head-and-neck tumors
20. GLUT1 glucose transporter expression in benign and malignant thyroid nodules
21. Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer
22. Immunohistochemical expression of glucose transporter-1 in human penile proliferative lesions
23. Expression of facilitative glucose transporter isoforms in lung carcinomas: Its relation to histologic type, differentiation grade, and tumor stage
24. Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases
25. Sequence and structure of a human glucose transporter
26. Immunohistochemical localization of glucose transporters in human renal cell carcinoma
27. Proliferating cell nuclear antigen expression at the invasive tumor margin predicts malignant potential of colorectal carcinomas
28. Proliferating cell nuclear antigen expression correlates with the meta-static potential of submucosal invasive colorectal carcinoma
29. Combined expression of urokinase-type plasminogen activator and proliferating cell nuclear antigen at the deepest invasive portion correlates with colorectal cancer prognosis
30. Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer
31. MUC-1 expression as a predictor of the curative endoscopic treatment of submucosally invasive colorectal carcinoma
32. Immunohistological detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues
33. Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase
34. Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas
35. Assessment of cell proliferation in colorectal carcinomas using the monoclonal antibody Ki-67
36. Predictive value of Ki-67 and argyrophilic nuclear organizer region staining for lymph node metastasis in gastric cancer
37. Overex-pression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastasis
38. GLUT1 glucose transporter expression in colorectal carcinoma: A marker for poor prognosis
39. The clinical significance of the histologic subclassification of colorectal carcinoma
40. Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis
41. Fluorodeoxy-glucose uptake in human cancer cell lines is increased by hypoxia
42. Negative regulation of hypoxia-inducible genes by the von-Hippel-Lindau protein